» Articles » PMID: 21863660

Can Valvular Interstitial Cells Become True Osteoblasts? A Side-by-side Comparison

Overview
Date 2011 Aug 26
PMID 21863660
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim Of The Study: Aortic valve calcification is believed to involve the differentiation of valvular interstitial cells (VICs) into either a myofibroblastic or an osteoblast-like phenotype. Despite purported similarities between diseased VICs and osteoblasts, few studies have directly compared VICs and osteoblasts in side-by-side experiments. In the present study, VICs were compared against multiple osteoblastic cell types at different stages of differentiation. These findings may help to resolve whether VICs progress through a myofibroblastic phenotype before reaching an osteoblast-like stage.

Methods: Three cell types representing a range of osteoblastic lineage commitment and differentiation were used in the phenotypic comparison against VICs. Specifically, VICs, embryonic fibroblasts (C3H10T1/2), pre-osteoblasts (MC3T3-E1), and mature primary osteoblasts were cultured on tissue-culture polystyrene in control or mineralization medium, and harvested for qPCR, DNA, and protein analysis at time points ranging from one to eight days.

Results: Culture of VICs in mineralization medium decreased the expression of alpha-smooth muscle actin (alpha-SMA; a myofibroblast marker), with no peak in alpha-SMA gene or protein expression in mineralization medium at any time point. The application of a mineralization medium led to increased expression levels of alkaline phosphatase (ALP; an early mineralization marker) for all cell types, although the magnitude of the increase in ALP was drastically smaller for VICs than for the osteogenic cell types. Only the osteogenic cell types demonstrated an appreciable increase in osteocalcin (an indicator of later-stage mineralization).

Conclusion: While the addition of mineralization medium generally increased the expression of osteogenic markers and decreased the expression of myofibroblastic markers, VICs displayed different levels and patterns of expression than the osteoblastic cell types used for comparison. Additionally, the lack of an alpha-SMA increase at any point after the addition of mineralization medium to VICs indicated that these cells may not need to progress through a myofibroblastic stage before reaching an osteoblast-like gene expression profile.

Citing Articles

Trymethylamine-N-oxide, a gut-derived metabolite, induces myofibroblastic activation of valvular interstitial cells through endoplasmic reticulum stress.

Sudi S, Suresh S, Kolli T, Porras A bioRxiv. 2025; .

PMID: 39975143 PMC: 11839121. DOI: 10.1101/2025.02.06.636980.


Genetics of Calcific Aortic Stenosis: A Systematic Review.

Vassiliou V, Johnson N, Langlands K, Tsampasian V Genes (Basel). 2024; 15(10).

PMID: 39457433 PMC: 11508093. DOI: 10.3390/genes15101309.


Osteopontin/SPP1: a potential mediator between immune cells and vascular calcification.

Zhao Y, Huang Z, Gao L, Ma H, Chang R Front Immunol. 2024; 15:1395596.

PMID: 38919629 PMC: 11196619. DOI: 10.3389/fimmu.2024.1395596.


Metformin ameliorates valve interstitial cell calcification by promoting autophagic flux.

Phadwal K, Tan X, Koo E, Zhu D, MacRae V Sci Rep. 2023; 13(1):21435.

PMID: 38052777 PMC: 10698150. DOI: 10.1038/s41598-023-47774-6.


CircRNA/lncRNA-miRNA-mRNA network and gene landscape in calcific aortic valve disease.

Zheng Y, Wen S, Jiang S, He S, Qiao W, Liu Y BMC Genomics. 2023; 24(1):419.

PMID: 37491214 PMC: 10367311. DOI: 10.1186/s12864-023-09441-y.


References
1.
Yin Yip C, Chen J, Zhao R, Simmons C . Calcification by valve interstitial cells is regulated by the stiffness of the extracellular matrix. Arterioscler Thromb Vasc Biol. 2009; 29(6):936-42. DOI: 10.1161/ATVBAHA.108.182394. View

2.
Taylor P, Batten P, Brand N, Thomas P, Yacoub M . The cardiac valve interstitial cell. Int J Biochem Cell Biol. 2002; 35(2):113-8. DOI: 10.1016/s1357-2725(02)00100-0. View

3.
Lian J, Gundberg C . Osteocalcin. Biochemical considerations and clinical applications. Clin Orthop Relat Res. 1988; (226):267-91. View

4.
Wu B, Elmariah S, Kaplan F, Cheng G, Mohler 3rd E . Paradoxical effects of statins on aortic valve myofibroblasts and osteoblasts: implications for end-stage valvular heart disease. Arterioscler Thromb Vasc Biol. 2004; 25(3):592-7. DOI: 10.1161/01.ATV.0000154278.01871.64. View

5.
Aikawa E, Nahrendorf M, Sosnovik D, Lok V, Jaffer F, Aikawa M . Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation. 2007; 115(3):377-86. DOI: 10.1161/CIRCULATIONAHA.106.654913. View